Clofazimine enteropathy in a pediatric bone marrow transplant recipient.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11295724.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clofazimine, previously used in the treatment of leprosy, is now used for treatment of Mycobacterium avium complex infection in patients with acquired immune deficiency syndrome, dermatologic disorders, and graft-versus-host disease. An 11-year-old boy developed a severe enteropathy 2 years after initiation of clofazimine treatment for graft-versus-host disease. Clofazimine enteropathy caused by crystal deposition can be life-threatening.
Medical subject headings
- Anti-Inflammatory Agents, Non-Steroidal
- Bone Marrow Transplantation
- Clofazimine
- Duodenal Diseases
- Graft vs Host Disease
- Ileal Diseases